2004
DOI: 10.1046/j.1399-0012.2003.00154.x
|View full text |Cite
|
Sign up to set email alerts
|

Aldosterone resistance in kidney transplantation is in part induced by a down‐regulation of mineralocorticoid receptor expression1

Abstract: The present data demonstrate that hyperkalemia and metabolic acidosis following CsA treatment in kidney transplantation might be associated with a down-regulation of MR expression on peripheral leukocytes. Electrolyte imbalance is reversible on application of fludrocortisone. This observation supports fludrocortisone treatment in transplant patients with severe electrolyte disturbances.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
38
0
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(40 citation statements)
references
References 21 publications
0
38
0
2
Order By: Relevance
“…Although some studies found CNIs to increase plasma renin activity (31, 32), others observed suppressed levels (13, 33, 34). Some studies showed that CNIs inhibit the mineralocorticoid receptor, and this effect was held to be responsible for signs of hypoaldosteronism such as hyperkalemia and acidosis (35, 36). Indeed, treatment with fludrocortisone alleviated these symptoms in kidney transplant patients (36).…”
Section: Vascular Effects Of Calcineurin Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Although some studies found CNIs to increase plasma renin activity (31, 32), others observed suppressed levels (13, 33, 34). Some studies showed that CNIs inhibit the mineralocorticoid receptor, and this effect was held to be responsible for signs of hypoaldosteronism such as hyperkalemia and acidosis (35, 36). Indeed, treatment with fludrocortisone alleviated these symptoms in kidney transplant patients (36).…”
Section: Vascular Effects Of Calcineurin Inhibitorsmentioning
confidence: 99%
“…Some studies showed that CNIs inhibit the mineralocorticoid receptor, and this effect was held to be responsible for signs of hypoaldosteronism such as hyperkalemia and acidosis (35, 36). Indeed, treatment with fludrocortisone alleviated these symptoms in kidney transplant patients (36). On the other hand, in rats, treatment with the mineralocorticoid receptor antagonist eplerenone also prevented some of the adverse effects of CNIs, including hypertension and reductions in glomerular filtration rate and renal blood flow (37).…”
Section: Vascular Effects Of Calcineurin Inhibitorsmentioning
confidence: 99%
“…According to recent studies, aldosterone resistance may also be associated with a reduction in MR expression, probably mediated by transcriptional mechanisms. [16][17][18][19] G protein-coupled receptor 48 (GPR48/ LGR4) belongs to the G protein-coupled receptor superfamily. It has recently been reported to bind R-spondin and mediate its signaling in intestinal crypt cells, 20,21 yet its function has not been well investigated.…”
Section: Introductionmentioning
confidence: 99%
“…It is noteworthy that not all studies demonstrated lower renin levels in CNItreated patients and, in fact, some studies demonstrated increases in renin levels, perhaps associated with CNI-induced renal vasoconstriction (7). Further work by Heering et al demonstrated that although mean aldosterone levels do not differ between CNI-treated transplant patients and normal controls, there was an almost four-fold decrease in the expression of the mineralocorticoid receptor in the peripheral leukocytes in CNI-treated patients (8). Despite this decrease in mineralocorticoid receptor expression, patients with hyperkalemia treated with fludrocortisone had improvement in both serum potassium levels and their metabolic acidosis.…”
Section: Case Discussionmentioning
confidence: 99%
“…Corticosteroid use suppresses production of adrenal corticosteroids and has a minor effect on aldosterone synthesis and thus would be unlikely to have a major effect on potassium homeostasis unless at high doses and associated with a marked catabolic effect. Heering et al demonstrated that aldosterone levels did not substantially differ between renal transplant patients and normal controls (8,22). Finally, upregulation of the aldosterone receptor in the distal tubule leads to increased sodium reabsorption as well as increased potassium excretion resulting in either normal or low serum potassium levels.…”
Section: Case Discussionmentioning
confidence: 99%